1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
(
- Contribution to journal › Article
- 2019
-
Mark
Preventive Effects of Epinephrine for Critically Ill Patients? More Questions Waiting to Be Answered
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
(
- Contribution to journal › Article
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
- 1989
-
Mark
Neuropeptides in the human appendix - Distribution and motor effects
(
- Contribution to journal › Article